NCT02729376View on ClinicalTrials.gov

Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

galeterone

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

LTN PHARMACEUTICALS, INC.

INDUSTRY